
ResMed RMD
$ 231.57
-0.52%
Annual report 2022
added 08-12-2022
Country |
![]() |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
CEO |
Mr. Michael Farrell |
Employees in the company |
7 770 |
Shares |
146 M |
Market Cap[1] |
$ 33.8 B |
EBITDA (LTM) |
$ 1.46 B |
P/E (LTM) |
31.64 |
P/S (LTM) |
7.06 |
EPS (LTM) |
6.78 |
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.